Kato Pharmaceuticals Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
Kato Pharmaceuticals General Information
Description
Operator of a clinical-stage bio-pharmaceutical platform designed to develop novel therapies for pathologies of the eye. The company's platform focuses on the unmet medical needs of the eye and offers therapies that separate the vitreous from the retina, enabling ophthalmologists to treat and reduce the risk of progression.
Contact Information
Website
www.katopharma.comCorporate Office
- 26051 Merit Circle
- Suite 102
- Laguna Hills, CA 92653
- United States
Corporate Office
- 26051 Merit Circle
- Suite 102
- Laguna Hills, CA 92653
- United States
Kato Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series C) | 25-Oct-2018 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 28-Jul-2016 | $6.09M | $9.8M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 15-May-2015 | $3.75M | $3.75M | Completed | Generating Revenue |
Kato Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 260,601 | $0.001000 | 8% | $14.39 | $14.39 | 1x | $14.39 | 16.79% |
Kato Pharmaceuticals Comparisons
Industry
Financing
Details
Kato Pharmaceuticals Competitors (4)
One of Kato Pharmaceuticals’s 4 competitors is Regeneron Pharmaceuticals, a Formerly VC-backed company based in Tarrytown, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals | Formerly VC-backed | Tarrytown, NY | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Roche | Corporation | Basel, Switzerland | ||||
| Bayer | Corporation | Leverkusen, Germany |
Kato Pharmaceuticals Patents
Kato Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017313907-A1 | Delivery of urea to cells of the macula and retina using liposome constructs | Active | 18-Aug-2016 | ||
| AU-2017313907-B2 | Delivery of urea to cells of the macula and retina using liposome constructs | Active | 18-Aug-2016 | ||
| US-11052158-B2 | Delivery of urea to cells of the macula and retina using liposome constructs | Active | 18-Aug-2016 | ||
| US-20190184030-A1 | Delivery of urea to cells of the macula and retina using liposome constructs | Active | 18-Aug-2016 | ||
| EP-3302061-A1 | Extended release urea compositions | Inactive | 05-Jun-2015 | A61K31/17 |
Kato Pharmaceuticals Signals
Kato Pharmaceuticals FAQs
-
When was Kato Pharmaceuticals founded?
Kato Pharmaceuticals was founded in 2011.
-
Where is Kato Pharmaceuticals headquartered?
Kato Pharmaceuticals is headquartered in Laguna Hills, CA.
-
What is the size of Kato Pharmaceuticals?
Kato Pharmaceuticals has 10 total employees.
-
What industry is Kato Pharmaceuticals in?
Kato Pharmaceuticals’s primary industry is Biotechnology.
-
Is Kato Pharmaceuticals a private or public company?
Kato Pharmaceuticals is a Private company.
-
What is Kato Pharmaceuticals’s current revenue?
The current revenue for Kato Pharmaceuticals is .
-
How much funding has Kato Pharmaceuticals raised over time?
Kato Pharmaceuticals has raised $17.8M.
-
Who are Kato Pharmaceuticals’s competitors?
Regeneron Pharmaceuticals, Novartis, Roche, and Bayer are competitors of Kato Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process